← Back to Patent Explorer
US4485174A Expired / Lapsed US ⏱️ 0.0 years remaining

Hemoglobin-based blood gas control

Assignee: IL Holding Spa
•
Filing: 1982-09-29
•
Granted: 1984-11-27
•
Expires: 2002-09-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Blood gas control containing hemoglobin, a pH buffering agent, and a reduced pyridine nucleotide capable of participating in a reaction which reduces methemoglobin to normal hemoglobin.

Inventors

  • 👤 Ching Chiang
  • 👤 Susan K. Bolton

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 23:15
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/26; C12Q1/32; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/72; G01N33/721; G01N33/96; G01N2333/00; G01N2333/795; G01N2333/805; G01N2496/00; G01N2496/70; Y; Y10; Y10T; Y10T436/00; Y10T436/10; Y10T436/102499; Y10T436/105831; Y10T436/108331

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 43 words
A control liquid having known pH, pCO 2 , and pO 2 for a blood gas analyzer or the like comprising hemoglobin, a pH buffering agent, and a reduced pyridine nucleotide capable of participating in a reaction which reduces methemoglobin to normal hemoglobin.
Claim 2
Dependent Claim 43 words
A control liquid having known pH, pCO 2 , and pO 2 for a blood gas analyzer or the like comprising hemoglobin, a pH buffering agent, and a reduced pyridine nucleotide capable of participating in a reaction which reduces methemoglobin to normal hemoglobin.
Claim 3
Dependent Claim 21 words
The control liquid of claim 1 and further including methemoglobin reductase and wherein said reduced pyridine nucleotide is NADPH or NADH.
Claim 4
Dependent Claim 54 words
The control liquid of claim 2 wherein said NADH or NADPH is provided by an NADH or NADPH generating system comprising one or more substrates and one or more enzymes reactive with said one or more substrates to generate sufficient NADH or NADPH to control the level of said methemoglobin in said control liquid.
Claim 5
Dependent Claim 49 words
The control liquid of claim 3 wherein said NADH or NADPH generating system is an NADH generating system comprising the chemical components L-lactic acid, NAD, and lactate dehydrogenase (LDH), said chemical components being present in amounts and proportions sufficient to generate said NADH according to the following reaction: ##STR2##
Claim 6
Dependent Claim 26 words
The control liquid of claim 1, further comprising a methemoglobin reductase and an organic phosphate capable of increasing and stabilizing the P 50 of said liquid.
Claim 7
Dependent Claim 13 words
The control liquid of claim 5 wherein said organic phosphate is inositol hexaphosphate.
Claim 8
Dependent Claim 23 words
The control liquid of claim 1, further comprising a base for raising the pH of said liquid to between about 7.0 and 8.0.
Claim 9
Dependent Claim 41 words
The control liquid of claim 1, said liquid being provided in a sealed container, said control liquid having a pH in the range of 7.0 to 8.0, carbon dioxide in the range of 1-7%, and oxygen in the range of 2-12%.
Claim 10
Dependent Claim 31 words
The control liquid of claim 1 further comprising a preservative present in a concentration sufficient to inhibit microbial growth in said liquid without impairing the quality control functions of said liquid.
Claim 11
Dependent Claim 11 words
The control liquid of claim 9 wherein said preservative is 2-phenoxyethanol.
Claim 12
Dependent Claim 134 words
The control liquid of claim 4, wherein said hemoglobin is provided as a component of a mammalian erythrocyte hemolysate which also contains said methemoglobin reductase, said hemolysate and said pH buffering agent being present in the respective proportions of between 1:1 and 3:1, by volume, said NAD is present in the concentration of between 0.1 mg and 1.0 mg per ml of liquid, said methemoglobin reductase is present in the concentration of between five and fifteen units per ml of liquid, said LDH is present in the concentration of between five and fifteen units per ml of liquid, said L-lactic acid is present in the concentration of between 0.02 M and 0.06 M per, and said pH buffering agent is TAPSO, BES, or TES in a concentration of between 0.05 M and 0.15 M.
Claim 13
Dependent Claim 46 words
The control liquid of claim 11, further comprising an organic phosphate capable of increasing and stabilizing the P 50 of said liquid, and a preservative present in a concentration sufficient to inhibit microbial growth in said liquid without impairing the quality control functions of said liquid.
Claim 14
Dependent Claim 18 words
The control liquid of claim 12 wherein said organic phosphate is inositol hexaphosphate and said preservative is 2-phenoxyethanol.
Claim 15
Dependent Claim 101 words
The control liquid of claim 13 wherein said hemolysate and said pH buffering agent are present in the respective proportions of 1:1, by volume, said LDH is present in the concentration of 7 units per ml of liquid, said L-lactic acid is present in the concentration of 0.04 M, said methemoglobin reductase is present in the concentration of 7 units per ml of liquid, said inositol hexaphosphate is present in the concentration of 1.4 mM, said NAD is present in the concentration of 0.5 mg per ml of liquid, and said 2-phenoxyethanol is present in the concentration of 0.4%, by volume.
Claim 16
Dependent Claim 58 words
The control liquid of any one of claims 1, 4 or 14 wherein said liquid is in a sealed container and has a hemoglobin content in the range of 6-22 g/dL, a pH in the range of 7.0 to 8.0, a carbon dioxide content in the range of 1-7%, and an oxygen content in the range of 2-12%.

References Cited (Backward Citations)

US3466249A Cited
US4049673A Cited
US3859049A Cited
US4102810A Cited
US4163734A Cited
US4001142A Cited
US3973913A Cited
US4112070A Cited
US4126575A Cited
US4199471A Cited
US4401122A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-11-27 1988-05-28 1988-11-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-11-27 1992-05-28 1992-11-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-11-27 1996-05-28 1996-11-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag